George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.42
Bid: 52.40
Ask: 52.42
Change: 0.12 (0.23%)
Spread: 0.02 (0.038%)
Open: 52.68
High: 52.82
Low: 52.32
Prev. Close: 52.30
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Suppl.Prospcts

27 Apr 2017 17:28

RNS Number : 6162D
Lloyds Banking Group PLC
27 April 2017
 

27 April 2017

 

Publication of Supplementary Prospectus

The following Supplementary Prospectus has been approved by the UK Listing Authority and is available for viewing:

Supplementary Prospectus dated 27 April 2017 (the "Supplementary Prospectus") relating to the £25,000,000,000 Euro Medium Term Note Programme of Lloyds Banking Group plc.

The Supplementary Prospectus should be read and construed in conjunction with the base prospectus dated 30 March 2017 (the "Base Prospectus").

To view the Supplementary Prospectus, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/6162D_-2017-4-27.pdf

The Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do.

For further information, please contact:

Investor Relations:

 

Douglas RadcliffeGroup Investor Relations Director 

Tel: +44 20 7356 1571

Email: douglas.radcliffe@finance.lloydsbanking.com

 

Corporate Affairs:

 

Matt Smith

Head of Corporate Media

Tel: +44 20 7356 3522

E-mail: matt.smith@lloydsbanking.com

 

Lloyds Banking Group plcRegistered OfficeThe MoundEdinburghEH1 1YZ

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in this announcement and the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom this announcement and the Supplementary Prospectus are not addressed. Prior to relying on the information contained in this announcement and the Supplementary Prospectus, you must ascertain from the Base Prospectus whether or not you are one of the intended addressees of the information contained in this announcement and the Supplementary Prospectus.

In particular, this announcement and the Supplementary Prospectus do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Supplementary Prospectus are not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States. For a description of the restrictions on offers and sales of the securities described herein, please refer to the Supplementary Prospectus and Base Prospectus.

Your right to access this service is conditional upon complying with the above requirement.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PSPEAKLXAASXEFF
Date   Source Headline
12th May 20235:25 pmRNSTransaction in Own Shares
11th May 20235:42 pmRNSTransaction in Own Shares
10th May 20235:22 pmRNSTransaction in Own Shares
10th May 20232:30 pmRNSDirector/PDMR Shareholding
9th May 20235:22 pmRNSTransaction in Own Shares
5th May 20235:33 pmRNSTransaction in Own Shares
5th May 202310:46 amRNSPublication of Suppl.Prospcts
4th May 20235:25 pmRNSTransaction in Own Shares
3rd May 20235:24 pmRNSTransaction in Own Shares
3rd May 202312:17 pmRNS2023 Q1 Interim Management Statement
3rd May 20237:00 amRNS2023 Q1 Interim Management Statement
2nd May 20236:01 pmRNSTransaction in Own Shares
28th Apr 20236:01 pmRNSTransaction in Own Shares
28th Apr 20233:52 pmRNSTotal Voting Rights
28th Apr 202310:10 amRNSReplacement: Notice of Redemption
28th Apr 20239:01 amRNSNotice of Redemption
27th Apr 20235:46 pmRNSTransaction in Own Shares
26th Apr 20235:36 pmRNSTransaction in Own Shares
25th Apr 20235:42 pmRNSTransaction in Own Shares
24th Apr 20235:35 pmRNSTransaction in Own Shares
21st Apr 20236:03 pmRNSTransaction in Own Shares
20th Apr 20235:53 pmRNSTransaction in Own Shares
19th Apr 20235:37 pmRNSTransaction in Own Shares
18th Apr 20235:45 pmRNSTransaction in Own Shares
17th Apr 20235:51 pmRNSTransaction in Own Shares
14th Apr 20236:12 pmRNSTransaction in Own Shares
13th Apr 20235:27 pmRNSTransaction in Own Shares
12th Apr 20235:23 pmRNSTransaction in Own Shares
12th Apr 20232:30 pmRNSDirector/PDMR Shareholding
11th Apr 20235:30 pmRNSTransaction in Own Shares
6th Apr 20235:38 pmRNSTransaction in Own Shares
5th Apr 20235:35 pmRNSTransaction in Own Shares
4th Apr 20235:55 pmRNSTransaction in Own Shares
4th Apr 20237:00 amRNSIFRS 17 Transition Document Issued
3rd Apr 20235:46 pmRNSTransaction in Own Shares
31st Mar 20235:40 pmRNSTransaction in Own Shares
31st Mar 20232:32 pmRNSTotal Voting Rights
30th Mar 20235:30 pmRNSTransaction in Own Shares
29th Mar 20236:16 pmRNSTransaction in Own Shares
28th Mar 20235:17 pmRNSTransaction in Own Shares
28th Mar 20234:45 pmRNSTotal Voting Rights
27th Mar 20235:18 pmRNSTransaction in Own Shares
24th Mar 20235:38 pmRNSTransaction in Own Shares
24th Mar 20239:12 amRNSNotice of Redemption
23rd Mar 20235:33 pmRNSTransaction in Own Shares
23rd Mar 20232:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20235:27 pmRNSTransaction in Own Shares
22nd Mar 202311:25 amRNS2022 Annual Report and Accounts
21st Mar 20235:55 pmRNSNotice of AGM
21st Mar 20235:40 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.